| 翻訳と辞書 |
BIT225
BIT225 is an experimental drug candidate under development by Biotron Limited for use in the treatment of both HIV and hepatitis C infection. By blocking Vpu ion channel activity, it disrupts HIV assembly within host monocyte cells; its method of action is a first for HIV drugs.〔(BIT225 therapy reduces HIV-1 burden in monocyte cells and decreases immune activation )〕 Because it targets replication in monocyte derived macrophages, it offers promise for treatment of viral reservoirs that are unaffected by standard treatments.〔(BIT225, a Novel Assembly Inhibitor, Cuts HIV Load in Monocyte Reservoir )〕 The activity of BIT225 is post-virus integration, with no direct effects on the HIV enzymes reverse transcriptase and protease.〔(Antiviral Efficacy of the Novel Compound BIT225 against HIV-1 Release from Human Macrophages )〕 Since Vpu ion channel activity is highly conserved, the virus is unlikely to become resistant via generation of Vpu ion-independent virus. In addition, the drug also has been credited with curing hepatitis C after 12 weeks of treatment.〔(BIT225 Trial Results Show Effective Cure of Hepatitis C )〕
==References==
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「BIT225」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|